S1P4 Regulates Passive Systemic Anaphylaxis in Mice but Is Dispensable for Canonical IgE-Mediated Responses in Mast Cells

Mast cells are key players in the development of inflammatory allergic reactions. Cross-linking of the high-affinity receptor for IgE (FcεRI) on mast cells leads to the generation and secretion of the sphingolipid mediator, sphingosine-1-phosphate (S1P) which is able, in turn, to transactivate its receptors on mast cells. Previous reports have identified the expression of two of the five receptors for S1P on mast cells, S1P1 and S1P2, with functions in FcεRI-mediated chemotaxis and degranulation, respectively. Here, we show that cultured mouse mast cells also express abundant message for S1P4. Genetic deletion of S1pr4 did not affect the differentiation of bone marrow progenitors into mast cells or the proliferation of mast cells in culture. A comprehensive characterization of IgE-mediated responses in S1P4-deficient bone marrow-derived and peritoneal mouse mast cells indicated that this receptor is dispensable for mast cell degranulation, cytokine/chemokine production and FcεRI-mediated chemotaxis in vitro. However, interleukin-33 (IL-33)-mediated enhancement of IgE-induced degranulation was reduced in S1P4-deficient peritoneal mast cells, revealing a potential negative regulatory role for S1P4 in an IL-33-rich environment. Surprisingly, genetic deletion of S1pr4 resulted in exacerbation of passive systemic anaphylaxis to IgE/anti-IgE in mice, a phenotype likely related to mast cell-extrinsic influences, such as the high circulating levels of IgE in these mice which increases FcεRI expression and consequently the extent of the response to FcεRI engagement. Thus, we provide evidence that S1P4 modulates anaphylaxis in an unexpected manner that does not involve regulation of mast cell responsiveness to IgE stimulation.

[1]  D. Metcalfe,et al.  Mast cells signal their importance in health and disease. , 2018, The Journal of allergy and clinical immunology.

[2]  C. Heidecke,et al.  S1P Signalling Differentially Affects Migration of Peritoneal B Cell Populations In Vitro and Influences the Production of Intestinal IgA In Vivo , 2018, International journal of molecular sciences.

[3]  B. Brüne,et al.  Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation , 2017, Mediators of inflammation.

[4]  S. Valitutti,et al.  IL‐33 fine tunes mast cell degranulation and chemokine production at the single‐cell level , 2017, The Journal of allergy and clinical immunology.

[5]  H. Germain,et al.  Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data , 2017, Scientific Reports.

[6]  R. Geha,et al.  IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells. , 2016, The Journal of allergy and clinical immunology.

[7]  F. Liew,et al.  Interleukin-33 in health and disease , 2016, Nature Reviews Immunology.

[8]  Jia Jia,et al.  Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits , 2016, Nature Genetics.

[9]  A. Olivera,et al.  Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. , 2016, European journal of pharmacology.

[10]  S. Nakae,et al.  Subcutaneous Allergic Sensitization to Protease Allergen Is Dependent on Mast Cells but Not IL-33: Distinct Mechanisms between Subcutaneous and Intranasal Routes , 2016, The Journal of Immunology.

[11]  B. Brüne,et al.  S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells , 2016, The Journal of Immunology.

[12]  G. Bandara,et al.  Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33 , 2015, European journal of immunology.

[13]  Xinzhong Dong,et al.  Identification of a mast cell specific receptor crucial for pseudo-allergic drug reactions , 2014, Nature.

[14]  J. Girard,et al.  Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells , 2014, Proceedings of the National Academy of Sciences.

[15]  Anne-Kathrin Kienzler,et al.  Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis. , 2014, The Journal of allergy and clinical immunology.

[16]  M. I. Crespo,et al.  Neutrophils Exhibit Differential Requirements for Homing Molecules in Their Lymphatic and Blood Trafficking into Draining Lymph Nodes , 2014, The Journal of Immunology.

[17]  Krisztina V. Vukman,et al.  Isolation and Culture of Peritoneal Cell-derived Mast Cells , 2014 .

[18]  Wei Zhang,et al.  Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice. , 2013, The Journal of allergy and clinical immunology.

[19]  P. Bruni,et al.  TGFβ1 evokes myoblast apoptotic response via a novel signaling pathway involving S1P4 transactivation upstream of Rho‐kinase‐2 activation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  F. Finkelman,et al.  Rapid polyclonal desensitization with antibodies to IgE and FcεRIα. , 2013, The Journal of allergy and clinical immunology.

[21]  A. Olivera,et al.  Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset. , 2013, Immunology letters.

[22]  K. Austen,et al.  Developmental origin and functional specialization of mast cell subsets. , 2012, Immunity.

[23]  B. Brüne,et al.  Apoptotic tumor cells induce IL‐27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity , 2012, European journal of immunology.

[24]  M. Tsai,et al.  IgE and mast cells in allergic disease , 2012, Nature Medicine.

[25]  J. Cyster,et al.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.

[26]  M. Lipp,et al.  Sphingosine‐1‐phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17‐cell differentiation in a murine model , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Lambris,et al.  G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. , 2011, European journal of pharmacology.

[28]  R. Proia,et al.  Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil Trafficking* , 2010, The Journal of Biological Chemistry.

[29]  H. Kuehn,et al.  Measuring Mast Cell Mediator Release , 2010, Current protocols in immunology.

[30]  B. Vanhaesebroeck,et al.  Btk-dependent Rac activation and actin rearrangement following FcεRI aggregation promotes enhanced chemotactic responses of mast cells , 2010, Journal of Cell Science.

[31]  R. Proia,et al.  Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. , 2010, The Journal of clinical investigation.

[32]  E. Crivellato,et al.  The mast cell: an evolutionary perspective , 2010, Biological reviews of the Cambridge Philosophical Society.

[33]  S. Milstien,et al.  Essential roles of sphingosine-1–phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema , 2010, The Journal of experimental medicine.

[34]  T. Moon,et al.  Advances in mast cell biology: new understanding of heterogeneity and function , 2010, Mucosal Immunology.

[35]  J. O’Shea,et al.  Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. , 2009, Immunity.

[36]  R. Proia,et al.  The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.

[37]  S. Milstien,et al.  Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. , 2008, Blood.

[38]  F. Finkelman Anaphylaxis: lessons from mouse models. , 2007, The Journal of allergy and clinical immunology.

[39]  R. Proia,et al.  The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. , 2007, Immunity.

[40]  H. Matsuyuki,et al.  Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. , 2006, Cellular & molecular immunology.

[41]  S. Payne,et al.  Role of ABCC1 in export of sphingosine-1-phosphate from mast cells , 2006, Proceedings of the National Academy of Sciences.

[42]  Shoko Iwaki,et al.  Generation, Isolation, and Maintenance of Rodent Mast Cells and Mast Cell Lines , 2006, Current protocols in immunology.

[43]  Christine Tkaczyk,et al.  Integrated signalling pathways for mast-cell activation , 2006, Nature Reviews Immunology.

[44]  R. Proia,et al.  IgE-dependent Activation of Sphingosine Kinases 1 and 2 and Secretion of Sphingosine 1-Phosphate Requires Fyn Kinase and Contributes to Mast Cell Responses* , 2006, Journal of Biological Chemistry.

[45]  E. Goetzl,et al.  Type 4 sphingosine 1‐phosphate G protein‐coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Johan Lennartsson,et al.  Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit , 2005, Stem cells.

[47]  D. Metcalfe,et al.  Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. , 2004, Blood.

[48]  J. Rivera,et al.  The ins and outs of IgE-dependent mast-cell exocytosis. , 2004, Trends in immunology.

[49]  R. Proia,et al.  Transactivation of Sphingosine-1–Phosphate Receptors by FcɛRI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis , 2004, The Journal of experimental medicine.

[50]  T. Gudermann,et al.  The sphingosine 1‐phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13 , 2003, Journal of cellular biochemistry.

[51]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[52]  G P Sapkota,et al.  Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. , 2001, Molecular cell.

[53]  J. Kinet,et al.  Minimal Requirements for IgE-Mediated Regulation of Surface FcεRI1 , 2001, The Journal of Immunology.

[54]  J. P. Hobson,et al.  Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. , 2000, Blood.

[55]  J. P. Hobson,et al.  Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor , 1999, The Journal of Biological Chemistry.

[56]  D. Linnekin,et al.  Early signaling pathways activated by c-Kit in hematopoietic cells. , 1999, The international journal of biochemistry & cell biology.

[57]  M. Lipp,et al.  EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. , 1998, Genomics.

[58]  C. Srikumari,et al.  Missense rhodopsin mutation in a family with recessive RP , 1994, Nature Genetics.

[59]  Z. Szallasi,et al.  Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. , 1993, The Journal of biological chemistry.

[60]  D. Katz,et al.  Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. , 1980, Journal of immunology.

[61]  R. Proia,et al.  Shaping the landscape: metabolic regulation of S1P gradients. , 2013, Biochimica et biophysica acta.

[62]  M. Tsai,et al.  Mast cells and immunoregulation/immunomodulation. , 2011, Advances in experimental medicine and biology.

[63]  A. Gilfillan,et al.  Regulation of mast cell responses in health and disease. , 2011, Critical reviews in immunology.

[64]  M. Maceyka,et al.  Extracellular and intracellular actions of sphingosine-1-phosphate. , 2010, Advances in experimental medicine and biology.

[65]  D. Metcalfe,et al.  Amplification mechanisms for the enhancement of antigen-mediated mast cell activation , 2009, Immunologic research.

[66]  M. Tsai,et al.  Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. , 2008, Journal of dermatological science.

[67]  J. Bienenstock,et al.  Mast cells , 2004, Springer Seminars in Immunopathology.

[68]  J. Kinet,et al.  Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. , 2001, Journal of immunology.

[69]  C. Bronner,et al.  Peptidergic pathway in human skin and rat peritoneal mast cell activation. , 1994, Immunopharmacology.

[70]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .